|
Volumn 67, Issue 1, 2009, Pages 141-142
|
Investigator-initiated pragmatic trials in developing countries - Much needed but much ignored
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
CHLORAMPHENICOL;
GENTAMICIN;
TRACE ELEMENT;
ACCREDITATION;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DRUG EFFICACY;
DRUG RESEARCH;
GOOD CLINICAL PRACTICE;
GOOD LABORATORY PRACTICE;
GOVERNMENT;
HEART INFARCTION;
HUMAN;
INFORMED CONSENT;
LETTER;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
CLINICAL TRIALS AS TOPIC;
DEVELOPING COUNTRIES;
RESEARCH PERSONNEL;
|
EID: 58149136354
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2008.03291.x Document Type: Letter |
Times cited : (10)
|
References (8)
|